Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 03, 2021
Pharmaron Beijing has entered into a definitive agreement to acquire Allergan Biologics Limited in Liverpool, UK, for US$118.7 million in cash from AbbVie.
read more
Monday, November 20, 2023
Ichor Life Sciences, a comprehensive contract research organization (CRO), has introduced Ichor Clinical Trial Services, expanding its capabilities to cater to the needs of biotechnology and pharmaceutical clients throughout the entire drug ...
read more
Worldwide Clinical Trials, Inc., (Worldwide) the industry’s leading global, midsized, full-service contract research organization (CRO), and Trialbee, a patient matching and enrollment company, today announced they are teaming up to streamline ...
read more
Almac Discovery, the research driven drug discovery company and a member of the Almac Group announced a new research collaboration with HitGen Inc., a provider of DNA-encoded library (DEL) technology for novel chemical equity (NCE) generation.
read more
We’ve long recognized that compounded drugs can serve an important role for patients whose medical needs cannot be met by an FDA-approved drug product.
read more
Monday, September 21, 2020
BioNTech will receive a grant by the German Federal Ministry of Education and Research to support the accelerated development of SARS-CoV-2 vaccines.
read more
Charles River Laboratories, International received regulatory approval, in the form of Good Manufacturing Practice (GMP) certification, to commercially produce allogeneic cell therapy drug products to distribute in Europe, from the European Medicines...
read more
Headlands Research announced its research centers have been selected to participate in AstraZeneca’s upcoming Phase III COVID-19 vaccine trial.
read more
Monday, September 14, 2020
Rockwell Medical has entered into an exclusive license agreement with Jeil for the rights to commercialize Triferic in South Korea.
read more
Wednesday, January 08, 2020
Sirnaomics and Innovent Biologics announced they have entered a strategic collaboration to conduct clinical studies, using STP705 and Tyvyt.
read more
Tuesday, February 18, 2014
INC Research, a therapeutically focused global clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today announced the appointment of Beatrice Setnik, PhD, as Vice President, Clinical Pharmacology. Dr. Setnik...
read more
Piramal Pharma Solutions has announced the appointment of Stuart E. Needleman as its Chief Commercial Officer.
read more
Thursday, December 16, 2021
Vifor Pharma Group announced the divestment of its finished drug product manufacturing business to CordenPharma, a full-service Contract Development & Manufacturing Organization (CDMO) of APIs, Excipients, Drug Products, and associated Packaging ...
read more
Dr. Reddy’s and its subsidiary, Promius Pharma announced the filing of NDA for its migraine candidate DFN-02 with the FDA.
read more
LabConnect has completed phase one of an 11,000+ square foot facility expansion in Johnson City, Tennessee.
read more